These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8948661)

  • 1. Treatment of agnogenic myeloid metaplasia with danazol: a report of four cases.
    Lévy V; Bourgarit A; Delmer A; Legrand O; Baudard M; Rio B; Zittoun R
    Am J Hematol; 1996 Dec; 53(4):239-41. PubMed ID: 8948661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Danazol treatment of idiopathic myelofibrosis with severe anemia.
    Cervantes F; Hernández-Boluda JC; Alvarez A; Nadal E; Montserrat E
    Haematologica; 2000 Jun; 85(6):595-9. PubMed ID: 10870115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rHuEpo for the treatment of anemia in myelofibrosis with myeloid metaplasia. Experience in 6 patients and meta-analytical approach.
    Rodríguez JN; Martino ML; Diéguez JC; Prados D
    Haematologica; 1998 Jul; 83(7):616-21. PubMed ID: 9718866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of danazol as a treatment for the anaemia of myelofibrosis with myeloid metaplasia: long-term results in 30 patients.
    Cervantes F; Alvarez-Larrán A; Domingo A; Arellano-Rodrigo E; Montserrat E
    Br J Haematol; 2005 Jun; 129(6):771-5. PubMed ID: 15953003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and hematological improvement in a patient receiving danazol therapy for myelofibrosis with myeloid metaplasia.
    Chabannon C; Pegourie B; Sotto JJ; Hollard D
    Nouv Rev Fr Hematol (1978); 1990; 32(2):165-6. PubMed ID: 2377449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy in agnogenic myeloid metaplasia and postpolycythemic myeloid metaplasia. A study of 34 cases.
    Brenner B; Nagler A; Tatarsky I; Hashmonai M
    Arch Intern Med; 1988 Nov; 148(11):2501-5. PubMed ID: 3190384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of anemia in idiopathic myelofibrosis with recombinant human erythropoietin.
    Hasselbalch HC; Clausen NT; Jensen BA
    Am J Hematol; 2002 Jun; 70(2):92-9. PubMed ID: 12111781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Danazol therapy for the anemia of myelofibrosis: assessment of efficacy with current criteria of response and long-term results.
    Cervantes F; Isola IM; Alvarez-Larrán A; Hernández-Boluda JC; Correa JG; Pereira A
    Ann Hematol; 2015 Nov; 94(11):1791-6. PubMed ID: 26122869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splenectomy for agnogenic myeloid metaplasia.
    Coon WW; Liepman MK
    Surg Gynecol Obstet; 1982 Apr; 154(4):561-3. PubMed ID: 7064091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Successful treatment of splenomegaly and anemia by VP therapy in idiopathic myelofibrosis complicated with acromegaly: a case report].
    Imai Y; Akiyama N; Hanazono Y; Inamori K; Mitani K; Hirai H; Nagai R; Yazaki Y
    Rinsho Ketsueki; 1995 Oct; 36(10):1233-6. PubMed ID: 8531337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal peliosis of the liver and spleen in a patient with agnogenic myeloid metaplasia treated with danazol.
    Makdisi WJ; Cherian R; Vanveldhuizen PJ; Talley RL; Stark SP; Dixon AY
    Am J Gastroenterol; 1995 Feb; 90(2):317-8. PubMed ID: 7847311
    [No Abstract]   [Full Text] [Related]  

  • 13. Interferon therapy for agnogenic myeloid metaplasia complicated by immune hemolytic anemia.
    Radin AI; Buckley P; Duffy TP
    Hematol Pathol; 1991; 5(2):83-8. PubMed ID: 1894585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Tefferi A
    Blood Rev; 2000 Sep; 14(3):121-9. PubMed ID: 10986148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients.
    Martínez-Trillos A; Gaya A; Maffioli M; Arellano-Rodrigo E; Calvo X; Díaz-Beyá M; Cervantes F
    Ann Hematol; 2010 Dec; 89(12):1233-7. PubMed ID: 20567824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
    Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
    J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive myelofibrosis in agnogenic myeloid metaplasia.
    Lohmann TP; Beckman EN
    Arch Pathol Lab Med; 1983 Nov; 107(11):593-4. PubMed ID: 6688716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agnogenic myeloid metaplasia with pulmonary hematopoiesis.
    Boula A; Mantadakis E; Xilouri I; Foudoulakis A; Samonis G
    Hematology; 2005 Dec; 10(6):501-3. PubMed ID: 16321815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics of agnogenic myeloid metaplasia: a study of 61 patients.
    Djordjevic V; Dencic-Fekete M; Jovanovic J; Bizic S; Jankovic G; Bogdanovic A; Cemerikic-Martinovic V; Gotic M
    Cancer Genet Cytogenet; 2007 Feb; 173(1):57-62. PubMed ID: 17284371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide therapy for myelofibrosis with myeloid metaplasia.
    Thomas DA; Giles FJ; Albitar M; Cortes JE; Verstovsek S; Faderl S; O'Brien SM; Garcia-Manero G; Keating MJ; Pierce S; Zeldis J; Kantarjian HM
    Cancer; 2006 May; 106(9):1974-84. PubMed ID: 16583431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.